Emergent BioSolutions Inc. (EBS)

CIK 0001367644 · NYSE · Pharmaceutical Preparations

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, Emergent BioSolutions Inc. reported revenue of $742.90M. Revenue fell 28.8% from the prior annual period.

Key ratios (year ended 2025-12-31)

13.5%

Operating margin

7.1%

Net margin

10.1%

Return on year-end equity

-28.8%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-09-01

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$742.90M	$1.04B	$1.05B	$1.12B	$1.77B	$1.58B	$1.11B	—	—	—
Cost of Revenue	$326.20M	$681.30M	$705.40M	$693.10M	$748.10M	$537.00M	$433.50M	$322.30M	$187.70M	$126.30M
Gross Profit	—	—	$317.60M	$383.00M	$891.30M	$925.20M	—	—	—	—
Operating Income	$100.10M	-$108.70M	-$726.40M	-$170.00M	$341.40M	$438.50M	$114.10M	$89.80M	$124.30M	$105.50M
Net Income	$52.60M	-$190.60M	-$760.50M	-$211.60M	$219.50M	$305.80M	$54.50M	$62.70M	$82.60M	$51.80M
EPS (Diluted)	$0.93	$-3.60	$-14.85	$-4.22	$4.06	$5.68	$1.04	$1.22	$1.71	$1.13
Total Assets	$1.32B	$1.39B	$1.82B	$3.17B	$2.96B	$2.88B	$2.33B	$2.23B	$1.07B	$970.11M
Total Liabilities	$796.00M	$906.90M	$1.17B	$1.78B	$1.35B	$1.44B	$1.24B	$1.22B	$157.90M	$373.91M
Shareholders' Equity	$522.60M	$482.80M	$649.30M	$1.39B	$1.61B	$1.45B	$1.09B	$1.01B	$912.30M	$596.20M
Cash & Equivalents	$205.40M	$99.50M	$111.70M	$642.60M	$576.10M	$621.30M	$167.80M	$112.20M	$178.30M	$271.50M
Operating Cash Flow	$170.60M	$58.70M	-$206.30M	-$34.10M	$320.20M	$536.90M	$188.00M	$41.80M	$208.10M	$54.60M
Capital Expenditures	$13.80M	$22.90M	$51.60M	$115.80M	$224.10M	$141.90M	$86.90M	$72.10M	$54.80M	$76.20M
Shares Outstanding	52.10M	54.30M	52.20M	50.10M	51.30M	53.10M	51.70M	51.20M	49.40M	40.57M
Weighted Average Diluted Shares	56.70M	53.00M	51.20M	50.10M	54.10M	53.80M	52.40M	51.40M	50.30M	49.30M
EPS (Basic)	$0.98	$-3.60	$-14.85	$-4.22	$4.10	$5.80	$1.06	$1.25	$1.98	$1.29